A range of new ads for the Australian and New Zealander wellness center will be removed from the websites of the Australian Health and Medical Research Council (AHPRC) and Health NZ, following the introduction of new anti-dosing rules.
The ads have been placed in Australia by Australian-based wellness center company Zen Health and the New Zealand-based Wellness NZ.
The changes, which will take effect in 2018, require that health and wellness products and services in the two countries must be tested for the presence of banned substances, including anti-inflammatories, for three days before being offered in Australia.
“Zen Health Australia has removed the Zen Health New Zealand wellness ads from its website,” said a statement from Zen Health.
Health NZ said the changes had been put in place to “provide clarity” about how the health profession tests for drugs. “
We are confident that the Australian authorities will soon remove all the ZenHealth New Zealand ads from their websites.”
Health NZ said the changes had been put in place to “provide clarity” about how the health profession tests for drugs.
“HealthNZ has no record of ZenHealth advertising on its website, and will not be providing any further comment on this matter,” it said.
Australian Health Minister Peter Dutton said he had not seen the ads, but was “disappointed” by them.
“I’ve never seen any health and wellbeing ads on their websites,” he said.
“They’ve got a whole bunch of stuff that’s all banned in Australia, so I just don’t understand why it would be acceptable for ZenHealth to advertise on their website.”
The Australian government, which has been grappling with a spiralling public health crisis, is set to approve a new anti‑doping regime by the end of June, which aims to tackle the widespread use of banned and unproven drugs by health professionals and health consumers.
Zen Health’s ads in New Zealand were not removed from ZenHealth’s site, which is run by the Australian Medical Association (AMA), despite being labelled as “anti-adherence” by the AMA.
ZenHealth Australia has not yet responded to BBC News’ request for comment.
AHPRC spokesman Chris Houghton said the change had been made “due to a new rule introduced by the government of New Zealand that requires all health and health care products to be tested by health and medical staff before being sold in Australia.”
“The AHPrc is currently assessing the new policy, and the decision will be made by the relevant AHPSC,” he added.
“AHPTC will be providing further information as soon as it is available.”
A Health NZ spokesman said the health council was aware of the ads and would be consulting with its stakeholders “as soon as possible”.
“Health NZ is committed to the health, wellbeing and well-being of all New Zealanders, and our ads comply with the health code.
We will ensure that all advertisements are in line with the code.”
The AMA said it would not be commenting.
Zen health’s ads appeared in a range of health and lifestyle products and were also placed on the website of the WellnessNZ New Zealand affiliate, the New South Wales Health Council.
The Australian Health Ministry said it had no record on ZenHealth ads.
Health NZ’s spokesperson said the AMA had been “very helpful” and was “working with the government to ensure that these advertisements are removed from all health websites”.
The AMA was not responding to BBC’s request for a comment.
The AMA, which runs the health codes of most states in the US, is responsible for regulating the use of medicines and is an official body of the AMA, a trade organisation.
The American Medical Association and other health bodies have been working to combat the use and abuse of banned drugs by medical professionals and consumers, as well as the misuse of prescription drugs.
Zenhealth said it was working to remove its ads from Zenhealth’s website and its New Zealand website.
“This is not the AMA’s first foray into Australia and we are fully aware of its rules and regulations,” the company said in a statement.
“As soon as we can, we will remove all ZenHealth products from our website.”
AHPNZ, a member of the AHP Group of companies, has been an active player in the Australian health care market, particularly in relation to anti-tumour treatments.
The group is part of the Health NZ alliance, which oversees Australia’s health system and has a role in ensuring that health care services are provided at a reasonable price to patients.
The association has received about $1 billion in public funds, including a $700 million federal grant, since 2010.
The health care industry has been a major driver of health care spending in Australia for decades.
The average cost of a patient’s visit to the doctor in Australia in 2017 was $4,500, according to the Australian Institute of Health and Welfare